Fennec Pharmaceuticals (FENC) Debt Ratio (2021 - 2022)
Fennec Pharmaceuticals' (FENC) quarterly Debt Ratio came in at 0.93 in Q4 2022, up 204.42% YoY from 0.3 in Q4 2021, and up 12.91% on a QoQ basis from 0.82 in Q3 2022.
Fennec Pharmaceuticals (FENC) Debt Ratio (2021 - 2022) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 2 years of Debt Ratio data on file, last reported at 0.93 in Q4 2022.
- Quarterly Debt Ratio rose 204.42% year-over-year to 0.93 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was 0.93 (up 204.42% YoY) and the FY2022 annual result came in at 0.93, up 204.42% from the prior year.
- Debt Ratio improved to 0.93 in Q4 2022, from 0.82 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.93 in Q4 2022 to a low of 0.07 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.12 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.47 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.26 |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 0.93 |
| Sep 30, 2022 | 0.82 |
| Jun 30, 2022 | 0.32 |
| Mar 31, 2022 | 0.26 |
| Dec 31, 2021 | 0.30 |
| Sep 30, 2021 | 0.07 |
| Jun 30, 2021 | 0.07 |